Stay updated on Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Sign up to get notified when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.

Latest updates to the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page
- Check4 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows an updated revision tag from v3.2.0 to v3.3.2, a minor UI/versioning change with no impact on study data or functionality.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding lapse notice banner on the page header was removed. The study history and record content remain unchanged.SummaryDifference0.6%

- Check54 days agoChange DetectedThe Old and New screenshots show the same Record History page with no substantive changes to trial data, status, or structure—only minor visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference11%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.